Novavax Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.11

+0.11 (+1.10%)

As of Sep 20, 10:12 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 67%

Hold 2 13%

Sell 3 20%

Price Target

Analyst Price Target +185.7% upside

Low Target $20.35

Average Target $28.88

High Target $29.25

Current Price $10.11

Current
$10.11

Target
$28.88

$20.35 $28.88 avg $29.25

Scenario Analysis

Bear Case

$20.35

101.3%

Low target

Base Case

$28.88

+185.7%

Avg target

Bull Case

$29.25

+189.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$11.97

-15.5% from high

52-Week Low

$6.20

+63.1% from low

Target vs 52W High

$28.88

+141.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%